These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20456287)

  • 21. High cocaine dosage decreases neurogenesis in the hippocampus and impairs working memory.
    Sudai E; Croitoru O; Shaldubina A; Abraham L; Gispan I; Flaumenhaft Y; Roth-Deri I; Kinor N; Aharoni S; Ben-Tzion M; Yadid G
    Addict Biol; 2011 Apr; 16(2):251-60. PubMed ID: 20731634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central stimulant abuse: neurochemistry and pharmacotherapy.
    Dackis CA; Gold MS; Pottash AL
    Adv Alcohol Subst Abuse; 1986; 6(2):7-21. PubMed ID: 2886014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The serotonergic system and its role in cocaine addiction.
    Filip M; Frankowska M; Zaniewska M; Gołda A; Przegaliński E
    Pharmacol Rep; 2005; 57(6):685-700. PubMed ID: 16382187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of medial prefrontal, entorhinal, and occipital 5-HT in cocaine-induced place preference and hyperlocomotion: evidence for multiple dissociations.
    Pum ME; Carey RJ; Huston JP; Müller CP
    Psychopharmacology (Berl); 2008 Dec; 201(3):391-403. PubMed ID: 18762916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic cocaine but not chronic amphetamine use is associated with perseverative responding in humans.
    Ersche KD; Roiser JP; Robbins TW; Sahakian BJ
    Psychopharmacology (Berl); 2008 Apr; 197(3):421-31. PubMed ID: 18214445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A neurocomputational model for cocaine addiction.
    Dezfouli A; Piray P; Keramati MM; Ekhtiari H; Lucas C; Mokri A
    Neural Comput; 2009 Oct; 21(10):2869-93. PubMed ID: 19635010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder.
    Howell LL; Cunningham KA
    Pharmacol Rev; 2015; 67(1):176-97. PubMed ID: 25505168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Withdrawal from chronic cocaine enhances behavioral sensitivity to the 5-HT2/1C agonist DOI.
    Baumann MH; Brockington AM; Rothman RB
    Biol Psychiatry; 1993 Oct; 34(8):576-7. PubMed ID: 8274588
    [No Abstract]   [Full Text] [Related]  

  • 29. Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction.
    Rothman RB; Blough BE; Baumann MH
    Trends Pharmacol Sci; 2006 Dec; 27(12):612-8. PubMed ID: 17056126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact on Cortical Function of Cocaine Abuse Co-Occurring with HIV.
    Napier TC
    Neuropsychopharmacology; 2017 Jan; 42(1):365. PubMed ID: 27909321
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of partial lesion of dorsal hippocampal afferent and GM1 ganglioside treatment on conditioned emotional response and hippocampal afferent markers in rats.
    Zieliński K; Walasek G; Werka T; Wesierska M; Gradkowska M; Oderfeld-Nowak B
    Behav Brain Res; 1993 May; 55(1):77-84. PubMed ID: 8329129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity.
    Maurice T; Martin-Fardon R; Romieu P; Matsumoto RR
    Neurosci Biobehav Rev; 2002 Jun; 26(4):499-527. PubMed ID: 12204195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonergic mechanisms in addiction-related memories.
    Nic Dhonnchadha BA; Cunningham KA
    Behav Brain Res; 2008 Dec; 195(1):39-53. PubMed ID: 18639587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developmental effects of prenatal cocaine exposure on 5-HT1A receptors in male and female rat offspring.
    Johns JM; Lubin DA; Lieberman JA; Lauder JM
    Dev Neurosci; 2002; 24(6):522-30. PubMed ID: 12697990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine D3 receptor function and cocaine exposure.
    Blaylock BL; Nader MA
    Neuropsychopharmacology; 2012 Jan; 37(1):297-8. PubMed ID: 22157862
    [No Abstract]   [Full Text] [Related]  

  • 36. PET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations.
    Gould RW; Duke AN; Nader MA
    Neuropharmacology; 2014 Sep; 84():138-51. PubMed ID: 23458573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine and preparatory behavior: I. Effects of pimozide.
    Blackburn JR; Phillips AG; Fibiger HC
    Behav Neurosci; 1987 Jun; 101(3):352-60. PubMed ID: 3606808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of animal models to develop antiaddiction medications.
    Gardner EL
    Curr Psychiatry Rep; 2008 Oct; 10(5):377-84. PubMed ID: 18803910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New concepts in cocaine addiction: the dopamine depletion hypothesis.
    Dackis CA; Gold MS
    Neurosci Biobehav Rev; 1985; 9(3):469-77. PubMed ID: 2999657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How fast and how often: The pharmacokinetics of drug use are decisive in addiction.
    Allain F; Minogianis EA; Roberts DC; Samaha AN
    Neurosci Biobehav Rev; 2015 Sep; 56():166-79. PubMed ID: 26116543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.